Arrowhead Pharmaceuticals (ARWR) Income from Discontinued Operations (2010 - 2013)

Arrowhead Pharmaceuticals (ARWR) has 4 years of Income from Discontinued Operations data on file, last reported at 336.0 in Q1 2013.

• Quarterly Income from Discontinued Operations rose 30.43% year-over-year to 336.0 in Q1 2013, while the trailing twelve-month figure through Sep 2013 was 354.0 (down 337.04% YoY) and the FY2013 annual result came in at 354.0, down 342.5% from the prior year.
• Income from Discontinued Operations fell to 336.0 in Q1 2013, from 18.0 in the prior quarter.
• In the past five years, Income from Discontinued Operations ranged from a high of 1574994.0 in Q4 2010 to a low of 768160.0 in Q2 2010.
• A 4-year average of 28586.42 and a median of 349.0 in 2011 frame the typical range for Income from Discontinued Operations.
• Annual changes were most pronounced in 2011 — Income from Discontinued Operations tumbled 100.01% — and 2012, when it jumped 100.98%.
• Tracing ARWR's Income from Discontinued Operations over 4 years: stood at 1574994.0 in 2010, then slumped by 100.01% to 220.0 in 2011, then surged by 91.82% to 18.0 in 2012, then sank by 1766.67% to 336.0 in 2013.
• The last three Income from Discontinued Operations figures came in at 336.0 (Q1 2013), 18.0 (Q4 2012), and 55.0 (Q3 2012), per Business Quant data.